Immunizations in Multiple Sclerosis: What You Need to Know
- Health Communicator
- Jun 22
- 6 min read
Updated: Jul 9
The information in this article is based on one of the most recent and authoritative scientific papers on vaccine-preventable infections and immunizations in patients with multiple sclerosis (MS) — “Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis” (Neurology, 2019). This document represents an updated guideline by the American Academy of Neurology (AAN), created by a multidisciplinary team of leading experts including neurologists, researchers, and clinicians with extensive academic and practical experience — Mauricio F. Farez, Jorge Correale, Melissa J. Armstrong, Alexander Rae-Grant, and others. Their recommendations and analyses, grounded in a systematic review of the scientific literature and rigorous evaluation of the evidence, have been accepted and endorsed by several professional organizations, including the Multiple Sclerosis Association of America and the Consortium of Multiple Sclerosis Centers.
The goal of the questions and answers presented here is to provide clarity and confidence for patients and their loved ones regarding the most important aspects of vaccination and infection prevention in MS — in the context of modern science and medical practice.
